Latest Debt Refinancing News

Whitehaven Coal reported a 29% drop in underlying net profit to $227 million for FY26, despite record safety outcomes and successful debt refinancing that lowered funding costs and extended maturities.

Region Group (ASX: RGN) delivered solid FY26 results with a 3.2% increase in Funds From Operations per security, a 9.8% total security holder return, and a leadership change as Greg Chubb took the helm as CEO.

Charter Hall Long WALE REIT reported a 128% surge in statutory profit to $275.9 million for FY26, supported by a $150.7 million property revaluation gain and a $248 million net acquisition spree. The REIT also completed a $2 billion debt refinancing, extending maturities and cutting margins.

HomeCo Daily Needs REIT reported a 44% jump in profit to $361.6 million for FY26, driven by strong property income and a $311 million portfolio valuation uplift. The REIT maintained stable distributions and upgraded its debt facilities with a BBB+ credit rating.

EBR Systems marked a commercial milestone with over 100 WiSE CRT implants and secured purchasing agreements with three major US healthcare networks. The company is progressing toward Medicare coverage and scaling manufacturing, supported by a near-complete A$150 million capital raise.

Southern Cross Media Group’s FY26 results reveal a 4.5% revenue drop amid a soft advertising market, but $30 million in merger synergies delivered a year early and digital revenue growth offer a silver lining.

Charter Hall Retail REIT's FY26 statutory profit soared 78% to $389.4 million, driven by a $305 million portfolio valuation uplift and a strategic pivot to convenience net lease retail assets. Distributions rose 3.3% amid a debt refinancing that lowered margins and extended maturities.

Centuria Office REIT swung to a $55.2 million profit in FY26, driven by solid leasing activity and a $1 billion debt refinancing that extended maturities and cut margins. The REIT maintained stable occupancy and delivered distributions in line with guidance, while setting a positive outlook for FY27.

Atomos Limited has turned a corner in FY26, posting over 20% sales growth to around $40 million and swinging to EBITDA profitability after prior losses, boosted by new product launches and the strategic acquisition of Flanders Scientific.

Mesoblast delivered US$115 million in Ryoncil® revenue in its first full year post-FDA approval, while expanding clinical trials into adult indications and acquiring cutting-edge CAR technology to boost its cell therapy pipeline.

Locality Planning Energy (ASX:LPE) posted positive operating cash flow for FY26 and secured three residential development partnerships, while planning to refinance its debt facilities to boost capital efficiency.

The Calmer Co International Ltd is raising up to $3.5 million through a 1-for-1 renounceable entitlement offer priced at $0.001 per share, including free attaching options exercisable at $0.002. The capital will fund debt repayment, inventory expansion, marketing, and product launches.